These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 32337633)

  • 41. What features improve the accuracy of the clinical diagnosis of progressive supranuclear palsy-parkinsonism (PSP-P)?
    Williams DR; Lees AJ
    Mov Disord; 2010 Feb; 25(3):357-62. PubMed ID: 20108379
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The contribution of cerebellar proton magnetic resonance spectroscopy in the differential diagnosis among parkinsonian syndromes.
    Zanigni S; Testa C; Calandra-Buonaura G; Sambati L; Guarino M; Gabellini A; Evangelisti S; Cortelli P; Lodi R; Tonon C
    Parkinsonism Relat Disord; 2015 Aug; 21(8):929-37. PubMed ID: 26077167
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Midbrain MRI assessments in progressive supranuclear palsy subtypes.
    Picillo M; Tepedino MF; Abate F; Erro R; Ponticorvo S; Tartaglione S; Volpe G; Frosini D; Cecchi P; Cosottini M; Ceravolo R; Esposito F; Pellecchia MT; Barone P; Manara R
    J Neurol Neurosurg Psychiatry; 2020 Jan; 91(1):98-103. PubMed ID: 31527182
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Diagnostic accuracy of parkinsonism syndromes by general neurologists.
    Joutsa J; Gardberg M; Röyttä M; Kaasinen V
    Parkinsonism Relat Disord; 2014 Aug; 20(8):840-4. PubMed ID: 24816002
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Transcranial sonography for the discrimination of idiopathic Parkinson's disease from the atypical parkinsonian syndromes.
    Bouwmans AE; Vlaar AM; Srulijes K; Mess WH; Weber WE
    Int Rev Neurobiol; 2010; 90():121-46. PubMed ID: 20692498
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The value of putaminal diffusion imaging versus 18-fluorodeoxyglucose positron emission tomography for the differential diagnosis of the Parkinson variant of multiple system atrophy.
    Baudrexel S; Seifried C; Penndorf B; Klein JC; Middendorp M; Steinmetz H; Grünwald F; Hilker R
    Mov Disord; 2014 Mar; 29(3):380-7. PubMed ID: 24243813
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Meta-analysis of the literature on diagnostic accuracy of SPECT in parkinsonian syndromes.
    Vlaar AM; van Kroonenburgh MJ; Kessels AG; Weber WE
    BMC Neurol; 2007 Sep; 7():27. PubMed ID: 17764571
    [TBL] [Abstract][Full Text] [Related]  

  • 48. 18F-FDG PET study on the idiopathic Parkinson's disease from several parkinsonian-plus syndromes.
    Zhao P; Zhang B; Gao S
    Parkinsonism Relat Disord; 2012 Jan; 18 Suppl 1():S60-2. PubMed ID: 22166456
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Utility of 18F FDG-PET in Parkinsonism in an African population.
    Amod FH; Bhigjee AI; Nyakale N
    eNeurologicalSci; 2022 Jun; 27():100399. PubMed ID: 35434388
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Volume of Interest Analysis of Spatially Normalized PRESTO Imaging to Differentiate between Parkinson Disease and Atypical Parkinsonian Syndrome.
    Sakurai K; Imabayashi E; Tokumaru AM; Ito K; Shimoji K; Nakagawa M; Ozawa Y; Shimohira M; Ogawa M; Morimoto S; Aiba I; Matsukawa N; Shibamoto Y
    Magn Reson Med Sci; 2017 Jan; 16(1):16-22. PubMed ID: 27001391
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Asymmetry index of Blink Reflex Recovery Cycle differentiates Parkinson's disease from atypical Parkinsonian syndromes.
    Sciacca G; Mostile G; Disilvestro I; Donzuso G; Manna R; Portaro G; Rascunà C; Salomone S; Drago F; Nicoletti A; Zappia M
    J Neurol; 2020 Jun; 267(6):1859-1863. PubMed ID: 32394017
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Machine learning on brain MRI data for differential diagnosis of Parkinson's disease and Progressive Supranuclear Palsy.
    Salvatore C; Cerasa A; Castiglioni I; Gallivanone F; Augimeri A; Lopez M; Arabia G; Morelli M; Gilardi MC; Quattrone A
    J Neurosci Methods; 2014 Jan; 222():230-7. PubMed ID: 24286700
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Different metabolic patterns analysis of Parkinsonism on the 18F-FDG PET.
    Juh R; Kim J; Moon D; Choe B; Suh T
    Eur J Radiol; 2004 Sep; 51(3):223-33. PubMed ID: 15294329
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The dopamine D2 receptor ligand 18F-desmethoxyfallypride: an appropriate fluorinated PET tracer for the differential diagnosis of parkinsonism.
    Schreckenberger M; Hägele S; Siessmeier T; Buchholz HG; Armbrust-Henrich H; Rösch F; Gründer G; Bartenstein P; Vogt T
    Eur J Nucl Med Mol Imaging; 2004 Aug; 31(8):1128-35. PubMed ID: 15042325
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The Role of Tau Imaging in Parkinsonian Disorders.
    Hammes J; Drzezga A; van Eimeren T
    Curr Neurol Neurosci Rep; 2018 Oct; 18(12):86. PubMed ID: 30293094
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Use of 11C-PE2I PET in differential diagnosis of parkinsonian disorders.
    Appel L; Jonasson M; Danfors T; Nyholm D; Askmark H; Lubberink M; Sörensen J
    J Nucl Med; 2015 Feb; 56(2):234-42. PubMed ID: 25593112
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Clinical, MRI and 18F-FDG-PET/CT analysis of progressive supranuclear palsy.
    Zhao P; Zhang B; Gao S; Li X
    J Clin Neurosci; 2020 Oct; 80():318-323. PubMed ID: 32651138
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Diagnostic value of 123I-ioflupane and 123I-iodobenzamide SPECT scans in 248 patients with parkinsonian syndromes.
    Vlaar AM; de Nijs T; Kessels AG; Vreeling FW; Winogrodzka A; Mess WH; Tromp SC; van Kroonenburgh MJ; Weber WE
    Eur Neurol; 2008; 59(5):258-66. PubMed ID: 18264015
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Classification of parkinsonian syndromes via factorial discriminant analysis of brain SPECT data].
    Kreisler A; Defebvre L; Duhamel A; Lecouffe P; Dujardin K; Steinling M; Pasquier F; Destée A
    Rev Neurol (Paris); 2009 May; 165(5):440-8. PubMed ID: 19150099
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Comparison of brain MRI and 18F-FDG PET in the differential diagnosis of multiple system atrophy from Parkinson's disease.
    Kwon KY; Choi CG; Kim JS; Lee MC; Chung SJ
    Mov Disord; 2007 Dec; 22(16):2352-8. PubMed ID: 17894342
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.